News

1. inVentiv Health Named A Top CRO From Among 2,000 Investigative Sites Surveyed By CenterWatch 5/15/2013

   inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, recently announced that inVentiv Health had been rated a Top CRO in a bi-annual survey by CenterWatch, a leading provider of global clinical trial information.

2. OsoBio Appoints David M. Lee Vice President Of Quality 5/13/2013

   OsoBio has named David M. Lee vice president of quality.

   Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality assurance.

   Lee brings to his role more than 20 years of professional experience managing quality operations and API and sterile manufacturing.

3. Chiltern Announces Senior Appointments Aimed At Securing The Company's Continued Success And Future Growth 5/13/2013

   Chiltern International Limited (Chiltern), a global contract research organization (CRO), announces the appointments of Dr Manuela Niewel and Lisa Bull to secure Chiltern’s continued success and future growth.

4. Chiltern Announces The Promotions Of Stuart McGuire And Jim Szymeczek 3/25/2013

   Chiltern International Limited (Chiltern), a global contract research organization (CRO), announces the promotions of Stuart McGuire and Jim Szymeczek.

5. INC Research Appoints James Taylor Vice President, Clinical Development 3/18/2013

   INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced James Taylor has joined the Company as Vice President, Clinical Development. Mr. Taylor joins INC Research from Pfizer, where he served most recently as Vice President, Global Clinical Trial management. In his new role, Mr. Taylor will serve as the primary liaison to biopharmaceutical customers, vendors and investigative sites for the Company's General Medicine Business Unit.

6. Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials 2/6/2013

   Exco InTouch, the leading provider of patient engagement, data collection and communication solutions for the pharmaceutical and healthcare sectors, recently announced that it has joined the Electronic Patient-Reported Outcome (ePRO) Consortium, a programme run by the Critical Path Institute (C-Path), which strives to enhance the quality of patient reported outcomes (PRO) in the evaluation of new pharmaceuticals.

7. inVentiv Health Recognized As 'Clinical Company Of The Year' 2/5/2013

   inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, recently announced that, at a ceremony in London, inVentiv Health was named “Clinical Company of the Year” by PharmaTimes.

8. Stiris Research And Statistics & Data Corp. Form Strategic Partnership 1/31/2013

   Stiris Research has entered into a strategic partnership with Statistics & Data Corporation (SDC) to offer seamless implementation of full-service Clinical + Biostatistics and Data Management/EDC solutions.  

9. Idenix Pharmaceuticals Announces Collaboration With Janssen To Initiate Phase II All-Oral Combination Studies Including IDX719, Simeprevir (TMC435) And TMC647055 For The Treatment Of Hepatitis C Virus (HCV) 1/28/2013

   Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced a non-exclusive collaboration with Janssen Pharmaceuticals, Inc. for the clinical development of all-oral direct-acting antiviral (DAA) HCV combination therapies.

10. ClinicalRM Awarded Contract For Regulatory, Clinical And Technical Services To Support The U.S. Army Medical Materiel Development Activity (USAMMDA) 11/15/2012

    Clinical Research Management, Inc. (ClinicalRM), a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today it was awarded a USAMMDA contract.